Ozempic alternatives: 4 options compared
Common reasons: shortage (less common now), insurance denied off-label weight-loss use, looking for higher weight-loss potency, or transitioning to obesity-labeled medication.
Last reviewed: June 2026 · Editorial pick at #1 · how we compare
Quick comparison table
| # | Alternative | Best for | Match type |
|---|---|---|---|
| 1 | Wegovy semaglutide | Patients without T2D who want FDA-labeled weight-loss path | Related indication (insurance pathway differs) |
| 2 | Mounjaro tirzepatide | T2D patients seeking greater HbA1c reduction and/or weight loss | Same FDA indication |
| 3 | Saxenda liraglutide | Patients on Medicare without T2D where Ozempic is denied and Wegovy is excluded by formulary | Different mechanism, same use case |
| 4 | Zepbound tirzepatide | Non-T2D patients seeking the most potent weight-loss option | Different mechanism, same use case |
Each alternative, in depth
#1 — Wegovy
★ Editorial picksemaglutide
Best for
Patients without T2D who want FDA-labeled weight-loss path
Key difference vs Ozempic
Same molecule (semaglutide), higher max dose (2.4 mg vs 2.0 mg), FDA-labeled for chronic weight management. Insurance often differs.
#2 — Mounjaro
tirzepatide
Best for
T2D patients seeking greater HbA1c reduction and/or weight loss
Key difference vs Ozempic
Tirzepatide (dual GIP/GLP-1) shown superior to semaglutide in head-to-head SURPASS-2 trial for HbA1c reduction at 40 weeks.
#3 — Saxenda
liraglutide
Best for
Patients on Medicare without T2D where Ozempic is denied and Wegovy is excluded by formulary
Key difference vs Ozempic
Daily liraglutide. Older drug with extensive real-world data. Lower weight-loss benefit but FDA-labeled for weight management.
#4 — Zepbound
tirzepatide
Best for
Non-T2D patients seeking the most potent weight-loss option
Key difference vs Ozempic
Tirzepatide labeled for weight management. Greater average loss than semaglutide. Different molecule — requires re-titration.
Frequently asked about Ozempic alternatives
Quick answers
›What's the difference between Ozempic and Wegovy alternatives?
Ozempic and Wegovy contain the same drug (semaglutide). Wegovy is the FDA-approved weight-loss formulation at higher doses. If you're using Ozempic off-label for weight loss, the appropriate switch is Wegovy, not a different molecule.
›Is Ozempic still in shortage?
No. Ozempic was removed from the FDA shortage list in early 2025 and is widely available as of 2026. Check our shortage tracker for current status.
›Can I take Mounjaro instead of Ozempic for diabetes?
Yes, often. Mounjaro (tirzepatide) is FDA-approved for T2D and has shown superior HbA1c and weight-loss outcomes vs semaglutide in head-to-head trials (SURPASS-2). Switch decisions are clinical and insurance-coverage dependent.
Why trust this comparison
Independent
No equity in any telehealth service. We earn affiliate commissions on click-through and never alter rankings for revenue.
Affiliate disclosure →Primary sources
Every clinical claim is cited to FDA labels, peer-reviewed trials with DOI links, or specialty-society guidelines. Never secondary sources.
Editorial methodology →Editorial-revenue separation
Commission rates do not affect ranking, scoring, or inclusion. We publish negative findings on paying affiliate partners.
Editorial policy →